FRDC has obtained Board approval FRDC Board Meeting # 194, 24 November 2022) to become a member of CRC SAAFE and investment up to $1.0 million. This project is needed to manage the FRDC investment that will be comprised of investments seafood related projects. Conducting projects within CRC SAAFE will provide linkages to additional resources, expertise and knowledge sharing that will improve project outputs and foster national collaboration in addition to that currently provided by the FRDC. Th ....FRDC has obtained Board approval FRDC Board Meeting # 194, 24 November 2022) to become a member of CRC SAAFE and investment up to $1.0 million. This project is needed to manage the FRDC investment that will be comprised of investments seafood related projects. Conducting projects within CRC SAAFE will provide linkages to additional resources, expertise and knowledge sharing that will improve project outputs and foster national collaboration in addition to that currently provided by the FRDC. This will include the research and industry participants that are partners of CRC SAAFE. Objectives: 1. Best practice AMR mitigation and management in the seafood industry and the aquatic environment. 2. Improved biosecurity and animal welfare through development of vaccines to minimise use of antibiotics. Read moreRead less
A Trivalent Vaccine For Sustainable Yellowtail Kingfish Growout
Funder
Fisheries Research and Development Corporation
Funding Amount
$809,040.00
Summary
Optimised vaccines deliver improved animal health and avoid use of antimicrobials in the production of fish (Sommerset et al., Expert Review Vaccines 2005, 4, 89-101.). Australian YTK Photobacteriosis outbreaks have been reported in association with Photobacterium damselae subsp damselae (Pdd), Photobacterium damselae subspecies piscicida(Pdp) and various Vibrio harveyi(Vh) isolates (Matt Landos, Nicky Buller, unpublished). To support stable production of high quality finfish highly efficacious ....Optimised vaccines deliver improved animal health and avoid use of antimicrobials in the production of fish (Sommerset et al., Expert Review Vaccines 2005, 4, 89-101.). Australian YTK Photobacteriosis outbreaks have been reported in association with Photobacterium damselae subsp damselae (Pdd), Photobacterium damselae subspecies piscicida(Pdp) and various Vibrio harveyi(Vh) isolates (Matt Landos, Nicky Buller, unpublished). To support stable production of high quality finfish highly efficacious controls of microbial diseases are critical. Successful examples are currently employed in salmon (Yersinia ruckeri, Vibrio anguillarum) and barramundi (Streptococcus iniae) whereby disease outbreaks drove the need for vaccine development. These conditions are now both well controlled in vaccinated populations and have dramatically reduced reliance on administration of antibiotics. Currently, crude autogenous vaccines are in use with YTK for control of only Pdd in South Australia and Western Australia with some reported success. Recently Pdp has emerged as a significant pathogen in South Australian outbreaks. Reliable vaccination against Pdp has proven difficult in international experience using traditional autogenous and generic killed vaccine methods, hence increasingly research is exploring DNA vaccination methods to improve protection against this pathogen (Kato et al., Vaccine 2015, 33 (8), 1040-1045). It is also probable that antigenic diversity had been underestimated, given high diversity that recent sequencing technology has revealed in our preliminary research . Preparedness for the emergence of highly pathogenic Pdp strains is prudent to allow rapid controls to be developed, without incurring business-ending losses within the growing aquaculture sector, or having high levels of reliance on oral antibiotics. Genetic sequence data on isolates generated through this project can be used for epidemiological modelling, new rapid diagnostic typing tools and immediate response if disease emergence occurs in other finfish industries. Pdp is acknowledged as a serious pathogen internationally in species including yellowtail, cobia, flounder, seabream, pompano and sea bass. (Andreoni et al.J Immunol Res. 2014).
Objectives: 1. Generate comprehensive genome database of Australian isolates of Pdd, Pdp and Vh associated with Photobacteriosis outbreaks in YTK 2. Generate and supply diagnostic laboratory reagents and methods for typing Photobacterium and Vibrio isolates associated with YTK outbreaks. 3. Deliver optimised monovalent and multivalent (Pdd, Pdp, Vh) killed vaccines, with production outline, appropriate adjuvant type, dose, safety and efficacy profile in YTK, ready for manufacture. Read moreRead less
Evaluation Of Cobia And Giant Groper Production And Health In Multiple Growout Systems, As An Alternative Species To Farm In WSSV Affected Areas Of South East Queensland
Funder
Fisheries Research and Development Corporation
Funding Amount
$150,000.00
Summary
The production and health performance of emerging aquaculture species, cobia and giant grouper, in former prawn farm pond and tank infrastructure is not well documented. The development of these alternative species offers flexibility and new production opportunities to WSSV affected farms in SE Queensland, and elsewhere in Australia to expand aquaculture production more generally.
Fish health problems are a common cause of aquaculture business failure. In prior pilot trials, significant ....The production and health performance of emerging aquaculture species, cobia and giant grouper, in former prawn farm pond and tank infrastructure is not well documented. The development of these alternative species offers flexibility and new production opportunities to WSSV affected farms in SE Queensland, and elsewhere in Australia to expand aquaculture production more generally.
Fish health problems are a common cause of aquaculture business failure. In prior pilot trials, significant health challenges were encountered that require thorough veterinary investigation and intervention. The information learnt from investigations can then form components of a health management plan for the culture of these two species in SE Queensland, in various systems. The description of health challenges through veterinary outbreak investigation allows the development and costing of interventions to prevent or treat the issue. Over the 12 month time frame of this project, surveillance strategies can be developed for early detection of disease. Such health management strategies facilitate early response actions that can minimise losses associated with infectious disease.
One metric which influences the viability of aquaculture systems is the density at which a species can be farmed. This is particularly the case in RAS, where the infrastructure capital costs are high. This project will document the impacts of stocking density on health and production in RAS, cages and ponds.
Another element that strongly influences viability of aquaculture enterprises is the growth rates of stock that are able to be achieved. Generating data from systems farmed at commercial densities can assist in determining the suitability of various sites for expansion of farming these species in Australia.
Objectives: 1. Generate data on the production and health performance of Giant Grouper and Cobia in RAS, cages in a saline lake and in outdoor pond growout systems. 2. Field test production outcomes from an experimental recombinant autogenous vaccine for prevention of nodavirus in the Giant Grouper. 3. Assess market potential for various formats of cobia and grouper Read moreRead less
Comparative Effectiveness Of Breast Tomosynthesis And Mammography In Real-world Population Screening: Evidence To Underpin And Improve Breast Cancer Screening
Funder
National Health and Medical Research Council
Funding Amount
$1,851,430.00
Summary
This research addresses key evidence gaps in breast cancer screening by investigating tomosynthesis (3D mammography) versus standard 2D mammography screening to establish the effectiveness of tomosynthesis in Australia and internationally, including impact on cancers not detected at screening that progress clinically. Large-scale studies will be done in real world screening services including a prospective comparative study planned collaboratively with BreastScreen to guide screening policy.
A Vision Of Healthy Urban Design For NCD Prevention
Funder
National Health and Medical Research Council
Funding Amount
$608,911.00
Summary
We are living in a new city era with new risks for health, and new ways to understand them. This project will combine state-of-the art methods in computer vision and artificial intelligence alongside co-creation of a web-based toolkit for action for use by city planners and urban designers that demonstrate practical pathways Improving our understanding of the strengths and limitations of existing city designs to ensure they are safe, clean, healthy, and sustainable.
Optimizing Immunotherapy Treatment For Breast Cancer Patients
Funder
National Health and Medical Research Council
Funding Amount
$1,938,014.00
Summary
The first steps in introducing immunotherapy for breast cancer patients have been taken in 2019. However, there is much work to do optimize immunotherapy for all breast cancer patients. My research, involving both lab and clinical trials, will develop new treatment strategies and identify new biomarkers to distinguish responders and non-responders. This will allow individualised selection of patients for evaluation of different immunotherapy approaches, with the aim of improving their survival.
Reducing Colorectal Cancer Burden In Young Adults: Precision Prevention And Early Detection
Funder
National Health and Medical Research Council
Funding Amount
$1,449,800.00
Summary
Bowel cancer rate in young adults before age 50 is increasing worldwide including Australia. Since it is impossible to screen everyone, it is critical to identify who is likely to develop the disease, to optimise screening. Using the world's largest resource for young-onset bowel cancer, I will conduct studies to generate high-quality evidence to inform how to best prevent bowel cancer in young adults and translate into the policy and practice, to reduce colorectal cancer burden in young adults.
Growth Regulatory Transcriptional Networks And Novel Therapies In Vascular Pathobiology
Funder
National Health and Medical Research Council
Funding Amount
$576,760.00
Summary
Cardiovascular disease and cancer together account for the majority of all deaths. Underpinning both these conditions are cellular and molecular changes in our blood vessels. This Fellowship will enable Professor Khachigian to enhance our understanding of fundamental mechanisms regulating the pathogenesis of vascular disease, and by harnessing this new knowledge in preclinical and human trials, generate novel strategies to combat a range of diseases through strategic partnership, collaboration a ....Cardiovascular disease and cancer together account for the majority of all deaths. Underpinning both these conditions are cellular and molecular changes in our blood vessels. This Fellowship will enable Professor Khachigian to enhance our understanding of fundamental mechanisms regulating the pathogenesis of vascular disease, and by harnessing this new knowledge in preclinical and human trials, generate novel strategies to combat a range of diseases through strategic partnership, collaboration and training.Read moreRead less
Creating Treatment Options For Endometrial Cancer Through High-level Clinical Trials
Funder
National Health and Medical Research Council
Funding Amount
$2,508,156.00
Summary
Endometrial cancer (EC) arises from the inner lining of the womb. Treatment typically involves surgery (hysterectomy) to remove the womb and explore if cancer has affected the lymph glands in the pelvis. The benefit of surgery on the lymph glands is doubtful. My research program will generate evidence to inform clinical practice on the treatment of EC and explore non-surgical treatment alternatives to a hysterectomy for better patient outcomes, particularly in women who wish to start a family.